Actively Recruiting
National Pregnancy Registry for Psychiatric Medications
Led by Massachusetts General Hospital · Updated on 2025-10-24
5000
Participants Needed
1
Research Sites
1308 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
A
Alkermes, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.
CONDITIONS
Official Title
National Pregnancy Registry for Psychiatric Medications
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women
- Age 18 to 45 years
- Willing to participate over the phone
- Able to provide informed consent
You will not qualify if you...
- Women who have completed their pregnancy
- Women planning to become pregnant
- Women not taking psychiatric medications or without history of psychiatric illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
B
Bryn Rediger
CONTACT
L
Lee Cohen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here